Milestone Pharmaceuticals Inc.

US$0.76As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:MISTHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR (35.83%)
Div yield —
ROE (35522.62%)
Biotechnology
Beta (5Y) 1.07
PE TTM —
TSR TTM (60.27%)
Mkt cap US$107.5M
ROIC (49.31%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.925
21.33%
(87.76%)
Hold 5|2|4|12|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
8.94%
8.82%
12.80%
9.38%
Revenue$M
7.281
7.468
7.313
7.250
14.25%
13.98%
7.39%
4.39%
Peers (US$107.5M)
Cap (US$)
PE
107.6M
—
Capital
TTM
5Y
10Y
Leveragex
0.902
1.088
1.129
EBIT/Intx
1.234
0.654
0.586
Own earn%
(287.78)
67.47
46.66
Sh yield%
29.04
30.53
31.51
Owners
Insiders/Inst%
9.92
45.41
Short interest%
3.96
SBC / revenue%
4.27
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
6–10
$1 testx
—
Incr. ROIC%
−1